HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard P Marshall Selected Research

Acids

1/2018Discovery of ( S)-3-(3-(3,5-Dimethyl-1 H-pyrazol-1-yl)phenyl)-4-(( R)-3-(2-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)ethyl)pyrrolidin-1-yl)butanoic Acid, a Nonpeptidic αvβ6 Integrin Inhibitor for the Inhaled Treatment of Idiopathic Pulmonary Fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard P Marshall Research Topics

Disease

10Idiopathic Pulmonary Fibrosis
03/2020 - 06/2015
5Fibrosis (Cirrhosis)
12/2021 - 07/2013
4Disease Progression
01/2020 - 12/2017
4Asthma (Bronchial Asthma)
10/2017 - 03/2009
3Inflammation (Inflammations)
01/2023 - 10/2002
2Neoplasms (Cancer)
01/2023 - 01/2016
2COVID-19
12/2021 - 01/2021
2Lung Injury
01/2004 - 01/2003
1Heart Diseases (Heart Disease)
01/2023
1Infections
12/2021
1Cough
01/2021
1Fever (Fevers)
01/2021
1Ageusia (Hypogeusia)
01/2021
1Anosmia
01/2021
1Dyspnea (Shortness of Breath)
01/2021
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2020
1Lung Neoplasms (Lung Cancer)
01/2019
1Nasal Polyps (Nasal Polyp)
10/2017
1Keloid
01/2017
1Weight Loss (Weight Reduction)
09/2013
1Overweight
09/2013
1Eosinophilia
09/2013
1Respiratory Hypersensitivity
03/2009
1Sarcoidosis (Schaumann Disease)
10/2006
1Lung Diseases (Lung Disease)
01/2004
1Acute Lung Injury
01/2004
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2003
1Wounds and Injuries (Trauma)
10/2002
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
09/2002
1Respiratory Insufficiency (Respiratory Failure)
09/2002

Drug/Important Bio-Agent (IBA)

5CollagenIBA
12/2021 - 01/2004
5IntegrinsIBA
12/2021 - 01/2018
4Biomarkers (Surrogate Marker)IBA
07/2019 - 07/2013
3Bleomycin (Blenoxane)FDA LinkGeneric
12/2021 - 01/2004
3Proteins (Proteins, Gene)FDA Link
01/2021 - 06/2015
3Transforming Growth Factor beta (TGF-beta)IBA
01/2020 - 01/2004
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
01/2004 - 09/2002
2ChAdOx1 nCoV-19IBA
12/2021 - 01/2021
2Transforming Growth Factors (Transforming Growth Factor)IBA
12/2021 - 01/2020
2catch-relaxing peptide (Mytilus)IBA
07/2019 - 06/2015
2omipalisibIBA
01/2019 - 01/2016
2mepolizumabIBA
10/2017 - 03/2009
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2006 - 10/2002
2ProstaglandinsIBA
10/2006 - 10/2002
2EnzymesIBA
10/2006 - 10/2002
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2004 - 01/2003
2Angiotensin IIIBA
01/2004 - 01/2003
1LectinsIBA
01/2023
1Galectin 3 (LGALS3)IBA
01/2023
1VaccinesIBA
12/2021
1CytokinesIBA
12/2021
1Nucleic AcidsIBA
01/2021
1LigandsIBA
01/2020
1GSK3008348IBA
01/2020
1Complement C3 (C3 Complement)IBA
07/2019
1Adenosine Triphosphate (ATP)IBA
01/2019
1Mechanistic Target of Rapamycin Complex 1IBA
01/2019
1Carbon MonoxideIBA
01/2019
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
01/2019
1TOR Serine-Threonine KinasesIBA
01/2019
1AcidsIBA
01/2018
1Albuterol (Salbutamol)FDA LinkGeneric
01/2018
1Blood Proteins (Serum Proteins)IBA
12/2017
1ChemokinesIBA
10/2017
1Phosphotransferases (Kinase)IBA
01/2016
1Peptide Hydrolases (Proteases)FDA Link
11/2015
1Matrix Metalloproteinases (MMPs)IBA
06/2015
1Interleukin-5 (Interleukin 5)IBA
09/2013
1Bronchodilator Agents (Bronchodilators)IBA
03/2009
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2006
1ProcollagenIBA
01/2004
1Angiotensin Receptor AntagonistsIBA
01/2003

Therapy/Procedure

6Therapeutics
01/2016 - 01/2004
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
09/2002